EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm is inviting investors who purchased ESSA Pharma Inc. (NASDAQ: EPIX) securities between December 12, 2023, and October 31, 2024, to join a securities fraud lawsuit. The deadline for lead plaintiff applications is March 25, 2025.
February 22, 2025 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is facing a securities fraud lawsuit, and investors who purchased shares between December 12, 2023, and October 31, 2024, can join the case. The lawsuit could impact the company's stock price and investor sentiment.
The announcement of a securities fraud lawsuit against ESSA Pharma is likely to negatively impact investor sentiment and the stock price in the short term. Legal issues can create uncertainty and potential financial liabilities for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100